What Is Just the Right Amount of Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema?: Protocol V and the Goldilocks Principle

JAMA Ophthalmol. 2021 Apr 1;139(4):381-382. doi: 10.1001/jamaophthalmol.2021.0013.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Diabetes Mellitus* / drug therapy
  • Diabetic Retinopathy* / physiopathology
  • Humans
  • Intravitreal Injections
  • Macular Edema* / drug therapy
  • Macular Edema* / physiopathology
  • Ranibizumab / therapeutic use

Substances

  • Ranibizumab